超声内镜成像用于诊断非酒精性脂肪性肝病
本研究评估超声内镜(EUS)诊断肝脂肪变的准确性。76例接受EUS引导下肝活检的患者中,EUS诊断肝脂肪变的准确性为0.8(95%CI 0.7-0.89),肥胖患者准确性为0.93(95%CI 0.8-0.99),非肥胖患者为0.69(95%CI 0.54-0.83)。EUS是诊断肝脂肪变的有用工具,尤其在腹部超声准确性有限的肥胖患者中。
要点
- EUS诊断肝脂肪变准确性为0.8(95%CI 0.7-0.89)。
- 肥胖患者EUS诊断肝脂肪变准确性为0.93(95%CI 0.8-0.99)。
- 非肥胖患者EUS诊断肝脂肪变准确性为0.69(95%CI 0.54-0.83)。
核心结论
- EUS是诊断肝脂肪变的有用工具,尤其在腹部超声准确性有限的肥胖患者中。
研究设计与样本
- 研究纳入本机构接受EUS引导下肝活检采样的所有患者,共76例。
- EUS肝脏图像由单一放射科医生使用4点超声评分量表评估肝脏回声强度。
- 肝活检标本由单一肝脏病理学家使用非酒精性脂肪性肝炎临床研究网络标准评估脂肪变和纤维化。
- 使用受试者工作特征曲线评估EUS诊断肝脂肪变的准确性,并对肥胖和非肥胖患者进行亚组分析。
主要发现
- 研究期间76例患者接受EUS引导下肝活检采样,平均年龄56.5岁,50%为女性,43.2%为肥胖。
- EUS诊断肝脂肪变的准确性为0.8(95%CI 0.7-0.89)。
- 肥胖患者EUS诊断肝脂肪变的准确性为0.93(95%CI 0.8-0.99),非肥胖患者为0.69(95%CI 0.54-0.83)。
- 肥胖患者中,EUS的阳性预测值为89.7%,阴性预测值为75%。
- EUS发现粗回声纹理诊断3级纤维化或肝硬化的准确性为79%。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: EUS is increasingly used to evaluate patients with liver disease, but its role in assessing hepatic steatosis has not been reported. The goal of our study was to assess the accuracy of EUS for diagnosing hepatic steatosis. METHODS: We identified all patients who underwent EUS-guided liver biopsy sampling at our institution. All digitally stored EUS liver images were reviewed by a single radiologist, who rated the severity of liver echogenicity using a 4-point US scale. Liver biopsy specimens for all study patients were reviewed by a single liver pathologist, who rated them for steatosis and fibrosis using Nonalcoholic Steatohepatitis Clinical Research Network criteria. Receiver operator characteristic curves were used to assess the diagnostic accuracy of EUS for hepatic steatosis for all patients and in a subgroup analysis for obese and nonobese patients. RESULTS: During the study period, 76 patients underwent EUS-guided liver biopsy sampling. The average age of study patients was 56.5 years, 50% were women, and 43.2% were obese. The accuracy for EUS for the diagnosis of hepatic steatosis was .8 (95% confidence interval [CI], .7-.89). The accuracy of EUS for the diagnosis of hepatic steatosis in obese patients was .93 (95% CI, .8-.99) and in nonobese patients was .69 (95% CI, .54-.83). For obese patients, EUS had a positive predictive value of 89.7% and a negative predictive value of 75%. The finding of course echotexture on EUS had an accuracy of 79% for the diagnosis of grade 3 fibrosis or cirrhosis. CONCLUSIONS: EUS is a useful tool for the diagnosis of hepatic steatosis, particularly in obese patients in whom abdominal US has modest accuracy.
引用
- Silva-Santisteban A, Agnihotri A, Cruz-Romero C, et al. EUS imaging for the diagnosis of nonalcoholic fatty liver disease. Gastrointest Endosc. 2021. PMID: 34915035. doi:10.1016/j.gie.2021.11.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。